This clinical-stage biotech develops oncology therapies targeting unmet needs in cancer and immune-mediated conditions.
This clinical-stage biotech develops bladder-sparing therapies for high-risk cancer patients, targeting unmet needs in oncology treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results